NEW YORK, June 24, 2016 /PRNewswire/ --
Since the financial crisis, the Healthcare sector has proven to
be defensive against market downturns, continuing to present
opportunities for growth. Today's featured companies on
Stock-Callers.com belong in this arena: Antares Pharma Inc.
(NASDAQ: ATRS), Globus Medical Inc. (NYSE: GMED), NuVasive Inc.
(NASDAQ: NUVA), and Insulet Corp. (NASDAQ: PODD). Learn more about
these stocks and receive your complimentary trade alerts at:
http://stock-callers.com/registration
To access Stock-Callers.com full PDF Research
Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
ATRS Research
Package: http://stock-callers.com/registration/?symbol=ATRS
GMED Research
Package: http://stock-callers.com/registration/?symbol=GMED
NUVA Research
Package: http://stock-callers.com/registration/?symbol=NUVA
PODD Research
Package: http://stock-callers.com/registration/?symbol=PODD
============
Ewing, New Jersey headquartered
specialty pharmaceutical Company, Antares Pharma Inc.'s stock
finished Thursday's session flat at $1.01. A total volume of 1.63 million shares was
traded, which was above their three months average volume of
776,250 shares. The Company's shares have advanced 16.09% in the
past one month and 42.25% over the previous three months. The stock
is trading above its 50-day moving average by 4.02%. Furthermore,
shares of Antares Pharma, which focuses on developing and
commercializing self-administered parenteral pharmaceutical
products and technologies globally, have a Relative Strength Index
(RSI) of 48.64.
On Thursday, shares in Audubon,
Pennsylvania headquartered medical device Company, Globus
Medical Inc., ended the session at $23.91, up 2.88%. The stock recorded a trading
volume of 356,178 shares. The Company's shares have gained 1.01% in
the last one month and 5.01% over the previous three months. The
stock is trading 0.63% below its 50-day moving average. Moreover,
shares of Globus Medical, which focuses on the design, development,
and commercialization of musculoskeletal implants that promote
healing in patients with spine disorders, have an RSI of 47.16.
San Diego, California
headquartered medical device Company, NuVasive Inc.'s stock ended
yesterday's session 1.85% higher at $58.86 with a total volume of 507,968 shares
traded. The Company's shares have advanced 8.70% in the past one
month, 26.25% over the previous three months, and 8.78% since the
start of this year. The stock is trading 8.43% above its 50-day
moving average and 17.34% above its 200-day moving average.
Additionally, shares of NuVasive, which develops and markets
minimally-disruptive surgical products and procedurally-integrated
solutions for spine surgery, have an RSI of 64.85.
At the close on Thursday, shares in Billerica, Massachusetts headquartered medical
device Company, Insulet Corp., recorded a trading volume of 572,649
shares. The stock finished 2.76% higher at $29.45. The Company's shares are trading below
their 50-day moving average by 4.83%. Furthermore, shares of
Insulet, which develops, manufactures, and sells insulin infusion
systems for people with insulin-dependent diabetes in the U.S.,
have an RSI of 42.90.
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored
reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and
micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
SC has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by SC. SC is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither SC nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our
coverage list contact us via email and/or phone between
09:30 EDT to 16:00 EDT from Monday to
Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street,
Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA